Harnessing Artificial Intelligence to Overcome Key Challenges in Psychedelic Research and Therapy
Artificial intelligence (AI) offers transformative potential in psychedelic research by addressing limitations in personalized treatment, predicting therapeutic outcomes, and understanding complex biological and environmental factors. AI-driven models provide new insights into long-term efficacy, set and setting optimization, and alternative treatment methods, advancing psychedelic therapy into personalized medicine.
Authors
- Robert B. Kargbo (ORCID: https://orcid.org/0000-0002-5539-6343)
Institutions
- Usona Institute (US)
Publication Details
- Journal
- ACS Medicinal Chemistry Letters
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1021/acsmedchemlett.4c00548
- Citations
- 1
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.64